[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control
Subcutaneous injections like semaglutide occasionally trigger localized itching, redness, or mild swelling at the injection site
In toxin-induced PD mouse models, DA-JC1, a novel dual GLP-1/GIP receptor agonist, improved motor impairment, increased the number of dopaminergic neurons in the substantia nigra, enhanced BDNF levels, and modulated apoptosis signaling pathways by altering the expression of Bax and Bcl-2 [89, 90]
They bind to its receptors, which are primarily located in the pancreas, brain, and gut
Lesin renal aguda , particularmente en pacientes con deshidratacin severa por vmitos o diarrea persistentes